BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10500060)

  • 1. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial.
    Attar A; Flourié B; Rambaud JC; Franchisseur C; Ruszniewski P; Bouhnik Y
    Gastroenterology; 1999 Oct; 117(4):794-7. PubMed ID: 10500060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].
    Bravo MV; Bunout D; Leiva L; de la Maza MP; Barrera G; de la Maza J; Hirsch S
    Rev Med Chil; 2008 Aug; 136(8):981-8. PubMed ID: 18949181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
    Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
    Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
    Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C
    Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth.
    Virally-Monod M; Tielmans D; Kevorkian JP; Bouhnik Y; Flourie B; Porokhov B; Ajzenberg C; Warnet A; Guillausseau PJ
    Diabetes Metab; 1998 Dec; 24(6):530-6. PubMed ID: 9932220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole.
    Hegar B; Hutapea EI; Advani N; Vandenplas Y
    J Pediatr (Rio J); 2013; 89(4):381-7. PubMed ID: 23796359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small bowel bacterial overgrowth is a common cause of chronic diarrhea.
    Teo M; Chung S; Chitti L; Tran C; Kritas S; Butler R; Cummins A
    J Gastroenterol Hepatol; 2004 Aug; 19(8):904-9. PubMed ID: 15242494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)--a pilot study.
    Khalighi AR; Khalighi MR; Behdani R; Jamali J; Khosravi A; Kouhestani Sh; Radmanesh H; Esmaeelzadeh S; Khalighi N
    Indian J Med Res; 2014 Nov; 140(5):604-8. PubMed ID: 25579140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics].
    Lykova EA; Bondarenko VM; Parfenov AI; Matsulevich TV
    Eksp Klin Gastroenterol; 2005; (6):51-7, 113. PubMed ID: 17378388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Small intestine bacterial overgrowth: six case reports and literature review].
    Karsenti D; Bechade D; Fallik D; Bili H; Desrame J; Coutant G; Algayres JP; Daly JP
    Rev Med Interne; 2001 Jan; 22(1):20-9. PubMed ID: 11218295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestine bacterial overgrowth: an underdiagnosed cause of diarrhea in patients with pancreatic cancer.
    Bustillo I; Larson H; Saif MW
    JOP; 2009 Sep; 10(5):576-8. PubMed ID: 19734643
    [No Abstract]   [Full Text] [Related]  

  • 14. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
    Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
    Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both.
    de Boissieu D; Chaussain M; Badoual J; Raymond J; Dupont C
    J Pediatr; 1996 Feb; 128(2):203-7. PubMed ID: 8636812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the rice breath hydrogen test for small intestinal bacterial overgrowth.
    Riordan SM; McIver CJ; Duncombe VM; Thomas MC; Bolin TD
    Am J Gastroenterol; 2000 Oct; 95(10):2858-64. PubMed ID: 11051360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth.
    Richard N; Desprez C; Wuestenberghs F; Leroi AM; Gourcerol G; Melchior C
    United European Gastroenterol J; 2021 Jul; 9(6):645-654. PubMed ID: 34241973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
    Donahue PE; Smith DL; Yellin AE; Mintz SJ; Bur F; Luke DR
    Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.
    Wiström J; Jertborn M; Ekwall E; Norlin K; Söderquist B; Strömberg A; Lundholm R; Hogevik H; Lagergren L; Englund G
    Ann Intern Med; 1992 Aug; 117(3):202-8. PubMed ID: 1616214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.